Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Michael Merchant
University of Louisville, Department: Internal Medicine/medicine
Should you be removed from our database? Contact us at [email protected]. Read more below.
Pharos Medicine
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Individual holds equity position in Pharos Medicine. If the results of the award are successful, Pharos Medicine would be in a potential favorable position to license any resulting technology. As Pharos Medicine is a start-up company, the actual value cannot be readily determined.
Novel biomarker validation and dosing algorithms for anemia management in ESRD
The empirical treatment of anemia with erythropoiesis stimulating agents does not achieve optimal results in a significant number of end-stage renal disease patients receiving hemodialysis. Our laboratories have independently identified candidate surrogate serum biomarkers of erythropoiesis in end-stage renal disease hemodialysis patients that are associated with treatment outcome and have led the development and testing of computation methods for dosing of erythropoiesis stimulating agents. We propose to merge these two novel advances and determine their combined utility to improve erythropoiesis stimulating agent dosing in end-stage renal disease.
Filed on September 25, 2015.
Tell us what you know about Michael Merchant's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Michael Merchant”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Michael Merchant | University of Louisville | Conflict of Interest | Pharos Medicine | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.